Evidence map›Paper›PMID 40840991›Full record

Observational studyBMJ open2025

Catch-up growth following early-life stunting in a low-resource area in rural Tanzania: the MAL-ED Metabolic study.

Kiya Nemati, Yotham Z Michael, Bernadetha P Hhando, Samwel Jatosh, Eric R Houpt, Estomih Mduma, Mark D DeBoer

2 registry-linked trialsAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02441426 unknown statusnot on this map

Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development

TypeobservationalSponsorFoundation for the National Institutes of HealthRan2008 to 2017Enrolled1,796ConditionsDiarrhea, Malnutrition, Stunting, Wasting
NCT05121935 not yet recruitingnot on this map

MAL-ED Metabolic: A Follow-Up of Chronic Disease at Puberty

TypeobservationalSponsorUniversity of VirginiaRan2022 to 2031Enrolled254ConditionsGrowth Failure, Intestinal Infection, Metabolic Syndrome, Glucose Intolerance
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kiya NematiPediatrics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Yotham Z MichaelCentre for Global Health, Haydom Lutheran Hospital, Mbulu, Tanzania, United Republic of.
Bernadetha P HhandoCentre for Global Health, Haydom Lutheran Hospital, Mbulu, Tanzania, United Republic of.
Samwel JatoshHaydom Lutheran Hospital, Mbulu, Tanzania, United Republic of.
Eric R HouptMedicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Estomih MdumaHaydom Lutheran Hospital, Mbulu, Tanzania, United Republic of.
Mark D DeBoerPediatrics, University of Virginia School of Medicine, Charlottesville, Virginia, USA deboer@virginia.edu.ORCID http://orcid.org/0000-0003-1462-591X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoor linear growth over time can lead to stunting, a significant public health problem in low-resource settings. Catch-up growth, the process of accelerated growth following growth faltering, is important for mitigating the long-term impacts of early stunting. This study aimed to identify key predictors of growth over time, stunting and catch-up growth among children in rural Tanzania.

methodsWe evaluated 182 children from the Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development cohort, whose anthropometric measurements were collected at six points from birth to 11.5 years. We assessed outcomes of height-for-age z-score (HAZ), stunting and catch-up growth using mixed-model linear and logistic regression to assess associations of maternal education, household income, socioeconomic status, insulin-like growth factor 1 (IGF-1) and thyroid function tests. We defined stunting as HAZ ≤-2 and catch-up growth both as stunting resolved from age 2 years to 11.5 years and a HAZ increase of >0.5 from 2 years to 11.5 years.

resultsCohort participants exhibited a moderate amount of catch-up growth, with per cent stunting decreasing from 72.6% at 2 years to 39.0% at 11.5 years. Maternal education, household income, socioeconomic status and IGF-1 were positively associated with HAZ (eg, IGF-1 point estimate 0.141±0.067, p=0.036) and negatively associated with odds of stunting across time points, while thyroid-stimulating hormone was negatively associated with HAZ and positively associated with odds of stunting (all p<0.05). For the definitions of catch-up growth, only IGF-1 was associated with odds of catch-up growth by both definitions (both p<0.01). Because of the potential for IGF-1 to be associated with maturation (and potential early growth cessation), we also assessed regression models that included IGF-1, luteinizing hormone and follicle-stimulating hormone, revealing that IGF-1 remained associated with catch-up growth (p<0.05).

conclusionsThese findings highlight the need for comprehensive interventions that address socioeconomic, hormonal and biological factors to promote catch-up growth and reduce stunting in resource-limited settings. The results offer valuable insights towards improving child health outcomes in similar contexts. TRIAL REGISTRATION NUMBER: NCT02441426 (post-results) and NCT05121935.

Indexed as

Child DevelopmentGrowth DisordersBody HeightChildChild, PreschoolFemaleHumansInfantInfant, NewbornInsulin-Like Growth Factor ILogistic ModelsMaleMalnutritionRisk FactorsRural PopulationSocioeconomic FactorsInsulin-Like Growth Factor INUTRITION & DIETETICSPaediatric endocrinologyTropical medicine

Identifiers

PMID40840991
PMCPMC12374642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.